Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection

Manjusha M Kulkarni1, Joseph Barbi, W Robert McMaster

  • 1Center for Microbial Interface Biology, The Ohio State University Medical Center, Columbus, OH, USA.

Cellular Microbiology
|April 20, 2011
PubMed

Insights

Cathelicidin-type antimicrobial peptides (CAMP) are crucial for controlling Leishmania parasite infections by modulating host immunity and preventing parasite spread. Lack of CAMP exacerbates lesions and promotes parasite dissemination, highlighting CAMP

Area of Science:

  • Immunology
  • Parasitology
  • Antimicrobial Peptides

Background:

  • Cathelicidin-type antimicrobial peptides (CAMP) are key innate immune mediators.
  • CAMP peptides disrupt microbial membranes and modulate host immune cell activity.
  • Leishmania parasites cause cutaneous infections, and their control involves host immune responses.

Purpose of the Study:

  • To investigate the role of CAMP in controlling cutaneous Leishmania infection.
  • To understand how CAMP influences host immune cell responses and parasite dissemination.
  • To explore the interaction between CAMP and Leishmania virulence factors.

Main Methods:

  • Utilized a CAMP knockout mouse model for Leishmania infection studies.
  • Assessed inflammatory infiltration, cytokine production (IL-10, IL-12, IFN-γ), and parasite dissemination.
  • Investigated the effect of Leishmania protease mutants on infection outcome.
  • Examined CAMP degradation by Leishmania protease in vitro.

Main Results:

  • CAMP-dependent inflammatory responses were observed in lesions and lymph nodes.
  • CAMP deficiency led to increased IL-10 receptor expression and IL-10 production, with reduced IL-12 and IFN-γ.
  • CAMP knockout mice exhibited exacerbated lesions and widespread parasite dissemination.
  • Leishmania protease degraded CAMP in vitro, suggesting a mechanism for immune evasion.

Conclusions:

  • CAMP plays a critical role in limiting Leishmania parasite dissemination and controlling infection severity.
  • Leishmania surface protease activity negatively regulates CAMP function, contributing to parasite survival.
  • This study reveals a complex interplay between CAMP, host immunity, and Leishmania virulence factors impacting infection outcomes.

Related Concept Videos

Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...